246 related articles for article (PubMed ID: 30842365)
21. Angiogenesis: from molecular mechanisms to translational implications.
Li B; Xiu R
Clin Hemorheol Microcirc; 2013; 54(4):345-55. PubMed ID: 23241508
[TBL] [Abstract][Full Text] [Related]
22. Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer.
Kim DS; Franklyn JA; Stratford AL; Boelaert K; Watkinson JC; Eggo MC; McCabe CJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1119-28. PubMed ID: 16394085
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis in endocrine glands: special reference to the expression of vascular endothelial growth factor.
Katoh R
Microsc Res Tech; 2003 Feb; 60(2):181-5. PubMed ID: 12539172
[TBL] [Abstract][Full Text] [Related]
24. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.
Kim CS; Ying H; Willingham MC; Cheng SY
Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711
[TBL] [Abstract][Full Text] [Related]
25. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.
Hoffmann S; Maschuw K; Hassan I; Wunderlich A; Lingelbach S; Ramaswamy A; Hofbauer LC; Zielke A
Endocrine; 2006 Aug; 30(1):129-38. PubMed ID: 17185801
[TBL] [Abstract][Full Text] [Related]
26. Regulation of tumor angiogenesis by the local environment.
Hall K; Ran S
Front Biosci (Landmark Ed); 2010 Jan; 15(1):195-212. PubMed ID: 20036815
[TBL] [Abstract][Full Text] [Related]
27. Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis.
Bousseau S; Vergori L; Soleti R; Lenaers G; Martinez MC; Andriantsitohaina R
Pharmacol Ther; 2018 Nov; 191():92-122. PubMed ID: 29909237
[TBL] [Abstract][Full Text] [Related]
28. [VEGFRs in neoplastic angiogenesis and prospects for therapy of brain tumors].
Korchagina AA; Shein SA; Gurina OI; Chekhonin VP
Vestn Ross Akad Med Nauk; 2013; (11):104-14. PubMed ID: 24640739
[TBL] [Abstract][Full Text] [Related]
29. Angiogenic and lymphangiogenic profiles in histological variants of papillary thyroid carcinoma.
Skuletic V; Radosavljevic GD; Pantic J; Markovic BS; Jovanovic I; Jankovic N; Petrovic D; Jevtovic A; Dzodic R; Arsenijevic N
Pol Arch Intern Med; 2017 Jun; 127(6):429-437. PubMed ID: 28425432
[TBL] [Abstract][Full Text] [Related]
30. Neovascularization: an attractive but tricky target in thyroid cancer.
Tasoulas J; Tsourouflis G; Theocharis S
Expert Opin Ther Targets; 2018 Sep; 22(9):799-810. PubMed ID: 30124087
[TBL] [Abstract][Full Text] [Related]
31. Endothelin-1 and angiogenesis in cancer.
Knowles J; Loizidou M; Taylor I
Curr Vasc Pharmacol; 2005 Oct; 3(4):309-14. PubMed ID: 16248773
[TBL] [Abstract][Full Text] [Related]
32. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor (VEGF) signaling in tumor progression.
Roskoski R
Crit Rev Oncol Hematol; 2007 Jun; 62(3):179-213. PubMed ID: 17324579
[TBL] [Abstract][Full Text] [Related]
34. Tumor angiogenesis and anti-angiogenic therapies.
Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
[TBL] [Abstract][Full Text] [Related]
35. Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges.
Siveen KS; Prabhu K; Krishnankutty R; Kuttikrishnan S; Tsakou M; Alali FQ; Dermime S; Mohammad RM; Uddin S
Curr Vasc Pharmacol; 2017; 15(4):339-351. PubMed ID: 28056756
[TBL] [Abstract][Full Text] [Related]
36. Angiogenic role of miR-20a in breast cancer.
Luengo-Gil G; Gonzalez-Billalabeitia E; Perez-Henarejos SA; Navarro Manzano E; Chaves-Benito A; Garcia-Martinez E; Garcia-Garre E; Vicente V; Ayala de la Peña F
PLoS One; 2018; 13(4):e0194638. PubMed ID: 29617404
[TBL] [Abstract][Full Text] [Related]
37. Paneling human thyroid cancer cell lines for candidate proteins for targeted anti-angiogenic therapy.
Hoffmann S; Wunderlich A; Celik I; Maschuw K; Hassan I; Hofbauer LC; Zielke A
J Cell Biochem; 2006 Jul; 98(4):954-65. PubMed ID: 16475167
[TBL] [Abstract][Full Text] [Related]
38. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
Roy R; Dagher A; Butterfield C; Moses MA
Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis and microvasculature in the female reproductive organs: physiological and pathological implications.
Shimizu T; Hoshino Y; Miyazaki H; Sato E
Curr Pharm Des; 2012; 18(3):303-9. PubMed ID: 22229567
[TBL] [Abstract][Full Text] [Related]
40. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors.
Hoffmann S; Hofbauer LC; Scharrenbach V; Wunderlich A; Hassan I; Lingelbach S; Zielke A
J Clin Endocrinol Metab; 2004 Dec; 89(12):6139-45. PubMed ID: 15579770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
